Learn more

BOEHRINGER MANNHEIM ITALIA

Overview
  • Total Patents
    248
About

BOEHRINGER MANNHEIM ITALIA has a total of 248 patent applications. Its first patent ever was published in 1985. It filed its patents most often in Italy, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and biotechnology are ATTARDO GIORGIO, RHONE POULENC RORER INT HOLDINGS INC and BIOENERGENIX LLC.

Patent filings per year

Chart showing BOEHRINGER MANNHEIM ITALIAs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Spinelli Silvano 130
#2 Menta Ernesto 74
#3 Gandolfi Carmelo A 66
#4 Tognella Sergio 60
#5 Long Giorgio 58
#6 Gallico Licia 56
#7 Rozzi Antonella 32
#8 Di Domenico Roberto 28
#9 Oliva Ambrogio 26
#10 Livi Valeria 21

Latest patents

Publication Filing date Title
WO9901462A1 Multinuclear cationic platinum complexes with antitumor activity
AU7040398A Bis-phosphonate confugates with alkylating moieties having antitumor activity
WO9823618A1 2,3,4,7-tetrahydropyridoindazole[1,4] benzodiazepine derivatives having antitumor activity
CA2234638A1 New bis-platinum complexes with polymethylene derivatives as ligands having antitumor activity
ZA9706422B New bis-platinum complexes with polymethylene derivatives as ligands having antitumor activity.
ZA9706421B New bis-platinum complexes with polyamine ligands as antitumor agents.
EP0887348A1 Bis-Indole derivatives having antimetastatic activity, a process for their preparation and pharmaceutical compositions containing them
AU3260897A Derivatives of carboxy gem-bisphosphonates with antitumor activity, a process for preparing them and pharmaceutical compositions containing them
AU1306197A Device for the carrying out of rapid diagnostic tests on samples of liquids
ITMI962241A1 Use of tetra:hydro-beta-carboline derivatives - for preparation of medicaments having anti-metastatic activity or tumour invasion or matrix metallo-proteinase inhibitory activity
EP0876369A1 2- 2- (2-HYDROXYETHYL)AMINO]ETHYL]-5- 2-METHYLAMINO)ETHYL]AMINO]INDAZOLO 4,3-gh]ISOQUINOLIN-6(2H)-ONE AS ANTITUMOR AGENT
ITMI960664A1 Use of tetra:hydro-beta-carboline derivatives - for preparation of medicaments having anti-metastatic activity or tumour invasion or matrix metallo-proteinase inhibitory activity
CA2205868A1 Trinuclear cationic platinum complexes having antitumour activity and pharmaceutical compositions containing them
US5587382A 6,9-bis[(2-aminoethyl) amino]benzo [g]isoquinoline-5,10- dione dimaleate; an aza-anthracenedione with reduced cardiotoxicity
ZA9503257B Hetero-annulated indazoles
MX9604390A Trinuclear cationic platinum complexes having antitumour activity and pharmaceutical compositions containing them.
AU2110995A Trinuclear cationic platinum complexes having antitumour activity and pharmaceutical compositions containing them
AU6997494A Method and analytical device for simultaneous immunoassay
US5506232A 6,9-bis[(2-aminoethyl)amino]benzo[g]isoquinoline-5,10-dione and its dimaleate salt
SG2094G Beta-carbonyl-carboxyamides of 1,3-thiazolidines